Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Oxford BioDynamics ( (GB:OBD) ) has shared an update.
Oxford BioDynamics has partnered with Regina Maria, Romania’s largest private healthcare provider, to offer its EpiSwitch PSE and CiRT clinical tests in Romania. This agreement allows Regina Maria to market and distribute these tests, enhancing their oncology portfolio and providing Romanian patients with access to high-accuracy diagnostic tests. The collaboration marks a strategic move for Oxford BioDynamics to expand its market presence in the EU, offering innovative solutions for prostate cancer screening and cancer immunotherapy response, thereby reinforcing Regina Maria’s position as a leader in next-generation health services.
More about Oxford BioDynamics
Oxford BioDynamics is a precision clinical diagnostics company that specializes in developing specific and sensitive medical tests using its EpiSwitch 3D genomics platform. The company focuses on bringing advanced diagnostic solutions to the medical field.
YTD Price Performance: -66.67%
Average Trading Volume: 11,717,279
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £9.98M
See more data about OBD stock on TipRanks’ Stock Analysis page.
